High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression

Lung Cancer

Volumn 34, Issue 2, 2001, Pages 233-241

  Ushijima, Chie ^a   Tsukamoto, Shuichi ^a   Yamazaki, Koji ^a   Yoshino, Ichiro ^a   Sugio, Kenji ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; CD34 and vascular endothelial growth factor; Non small cell lung cancer; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY CD3; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0034781856     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00246-X     Document Type: Article

References (33)

1. Vital static's of Japan 1997
2. Implications of staging in lung cancer
3. Revisions in the international system for staging lung cancer
4. Prognostic markers in resectable non-small cell lung cancer
5. A prognostic model of recurrence and death in stage I non-small-cell lung cancer utilizing presenting symptoms, histopathology and oncoprotein expression
6. Immunocytochemical markers in stage I lung cancer: Relevance to prognosis
7. Non-small cell lung cancer: Clinical value of new biological predictors
8. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications
9. Induction of angiogenesis during the transition from hyperplasia to neoplasia
10. Novel growth regulatory factors and tumour angiogenesis
11. Angiogenesis in cancer, vascular, rheumatoid and other disease
12. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
13. The implications of angiogenesis for the biology and therapy of cancer metastasis
14. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature
15. Relation of neovascularisation to metastasis of non-small-cell lung cancer
16. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
17. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas
18. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer
19. Prognostic value of angiogenesis in operable non-small cell lung cancer
20. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence
21. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer
22. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
23. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer
24. Heterogeneity in microvascular density in lung tumours: Comparison with normal bronchus
25. Vascular endothelial growth factor is a secreted angiogenic mitogen
26. Vascular permeability factor, an endothelial cell mitogen related to PDGF
27. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
28. Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
29. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer
30. The biology of vascular endothelial growth factor
31. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis
32. p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival
33. K-ras and p53 mutations are an independent unfavourable prognostic indicatorin patients with non-small-cell lung cancer